Kontoor Brands, Inc.
For the period ended Oct 3, 2026. Filed Nov 5, 2026.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Oct 3, 2026 · Filed Nov 5, 2026
What changed in Risk Factors?
Read the current filingPrevious report: 10-Q
Period ended 2026-07-04; filed 2026-08-12.
0001760965-26-000059
Item 1A. Risk FactorsCurrent report: 10-Q
Period ended 2026-10-03; filed 2026-11-05.
0001760965-26-000075
Item 1A. Risk FactorsThe baseline is this issuer’s latest earlier reporting period of the same form that was filed before the current report. A previous 10-Q is a different quarter, not a year-over-year comparison. Amendments are excluded.
Compared 10 previous paragraphs and 5 current paragraphs.
4 unchanged; 1 reworded; 0 added; 5 removed; 0 previous and 0 current paragraphs rearranged.
Tables are not compared: 0 previous and 0 current tables excluded. Dates, whitespace, punctuation and numbering changes are ignored; changes to financial figures remain significant.
A changed paragraph is not evidence that risk increased or decreased. An unchanged paragraph does not establish that risk stayed the same.
Removed paragraphs (5)
Previous report
The completion of the sale of the Lee® business is subject to various risks, uncertainties and conditions and may not be completed on the terms or timeline currently contemplated, if at all.
Previous report
On May 20, 2026, the Company entered into the Stock Purchase Agreement (the “Purchase Agreement”) with ABG-Storm LLC, a Delaware limited liability company, an affiliate of Authentic Brands Group and The H.D. Lee Company, Inc., a Delaware corporation and wholly-owned subsidiary of the Company ("Lee") , pursuant to which, subject to the terms and conditions set forth therein, the Company has agreed to sell to ABG-Storm LLC all of the outstanding shares of capital stock of Lee for $750 million in cash at closing with an additional $250 million earnout opportunity based on the future performance of Lee over a five-year period. The Purchase Agreement provides that completion of the sale of Lee is subject to the satisfaction or waiver of certain customary closing conditions, including, among other things, the receipt of regulatory approvals. There can be no assurance regarding the timing of the completion of the transaction or that the transaction will be completed. Unanticipated developments could delay, prevent or otherwise adversely affect the transaction, including, but not limited to, potential issues or delays in obtaining various regulatory approvals. In addition, each party has the right to terminate the Purchase Agreement under specified circumstances, including if the closing of the transaction has not occurred on or before February 1, 2027.
Previous report
We may be exposed to liabilities or losses from operations that we have or will discontinue or otherwise sell, including our Lee® business.
Previous report
The Company commenced a sale process for the global Lee® business during the first quarter of 2026 and determined that the Lee® business should be presented as discontinued operations. We intend to sell the Lee® business by the end of fiscal 2026; however, we cannot assure that we will complete a transaction under terms favorable to the Company, or even at all. Similarly, we may incur unanticipated additional costs in connection with the sale of the Lee® business. If we are not able to sell the Lee® business on terms favorable to the Company, our results of operations, cash flows and financial condition could be materially adversely affected.
Reworded paragraphs (1)
Previous wording
Careful consideration of the risk factors set forth under Part I, Item 1A, “Risk Factors,” of our 2025 Annual Report on Form 10-K should be made. Except for the addition of the risk factors set forth below, there have been no material changes to the risk factors from those disclosed in Part I, Item 1A of our 2025 Annual Report on Form 10-K.
Current wording
Careful consideration of the risk factors set forth under Part I, Item 1A, “Risk Factors,” of our 2025 Annual Report on Form 10-K should be made. Except for the addition of the risk factor set forth below, there have been no material changes to the risk factors from those disclosed in Part I, Item 1A of our 2025 Annual Report on Form 10-K.